The anti-snoring devices market is projected to grow from US$ 1.81 billion in 2025 to US$ 3.36 billion by 2033, growing at a CAGR of 8.04% between 2025 and 2033. The factors driving this growth include an increasing prevalence of obesity, the introduction of advanced technological devices, a preference for non-invasive treatments, and the availability of minimally invasive surgical options, strategic initiatives by major players operating in the market, and easy access to products through online and offline channels.
Anti-snoring devices are those designed to minimize or eliminate snoring, a common problem affecting millions in the world's population. These work by trying to eliminate the basic causes of snoring, which include nasal obstruction, throat muscle relaxation, and even tongue positioning. Examples of common types include mouthguards, nasal strips, and positional aids that encourage side sleeping.
Because people are becoming more conscious of the health dangers associated with snoring, these devices have become very popular over recent years. For example, obstructive sleep apnea has been linked to serious conditions like high blood pressure, heart disease, and sleep deprivation. More people are turning toward anti-snoring solutions as a means to improve their rest amidst growing awareness of quality sleep.
Further, the introduction of e-commerce gave the consumer easier access to different anti-snoring solutions globally. Online reviews and recommendations motivated this interest, leading to a broader level of acceptance and demand for such innovative solutions. Therefore, anti-snore devices represent a market with continuous growth, proposing different options that consider every preference and need.
Headquarters: Netherlands
Koninklijke Philips NV (Philips) is a diversified technology company engaged in the development of medical systems and the manufacturing of consumer electronics products. The company's products are focused on precision diagnosis, image-guided therapy, monitoring, enterprise informatics, sleep and respiratory care, and personal health. Its major products and services include X-ray and fluoroscopy systems, MRI systems, CT systems, integrated interventional X-ray systems, image guided therapy system, ICE catheter, hospital patient monitoring systems, ambulatory monitoring and diagnostics systems, battery-operated toothbrushes, brush heads, breast pumps, baby bottles, sterilizers, groomers, trimmers, and hair clippers, among others. The company's products are distributed to healthcare providers, patients, and consumers in Europe, North America, and Asia.
Headquarters: United States of America
ResMed Inc (ResMed) is a medical device company. It develops, manufactures, and distributes medical equipment for the diagnosis, treatment, and management of respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea, and chronic obstructive pulmonary disease (COPD). Its major products include airflow generators comprising continuous positive airway pressure (CPAP) devices, auto-bilevel devices, variable positive airway pressure (VPAP) devices, and automatic positive airway pressure (APAP) devices. The company distributes its products in various countries through both a combination of distributors and direct sales teams. ResMed also offers software as a service to out-of-hospital health providers. The company sells its products to sleep clinics, home healthcare dealers, and third-party payers.
Headquarters: Australia
SomnoMed Limited is a global leader in the development and manufacturing of innovative oral appliances for the treatment of sleep-related disorders, focusing on Obstructive Sleep Apnea (OSA). This Australian company was founded in 2004 in Sydney and is specialized in the design of effective, patient-friendly solutions that lead to improved quality of sleep and health. The flagship product at SomnoMed is the SomnoDent, which is a custom-made oral device designed to keep the airway open during sleep. It is more comfortable compared to CPAP machines. The company has established an international presence, distributing its products in many countries and expanding further. Committed to research and development, SomnoMed invests significantly in clinical studies to enhance its offerings, aiming to provide healthcare professionals and patients with reliable, effective options for better health regarding sleep.
Headquarters: United Kingdom
GSK plc is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines. GSK's major products encompass specialty medicines, vaccines, and general medicines targeting therapeutic areas such as HIV, respiratory, cancer, immuno-inflammation, anti-viral, central nervous system (CNS), metabolic, cardiovascular, and urogenital, anti-bacterial, dermatology, and rare diseases. The company also offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health, and gastrointestinal diseases. GSK's vaccine portfolio covers various diseases, including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles, and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians, and other groups globally.
Headquarters: United States
Apnea Sciences Corporation is a groundbreaking organization committed to researching and developing novel approaches for diagnosing and treating sleep apnea, among other sleep disorders. Driven by a passion for helping improve the quality of life for those afflicted, it merges advanced medical technology with in-depth research. Its flagship product is a non-invasive device that reduces discomfort and increases patient compliance while offering effective therapy. Emphasizing clinical efficacy and safety, this organization ensures its solutions are scientifically researched and proven. Besides the product offering, Apnea Sciences Corporation actively participates in education and awareness on sleep disorders. With emphasis on patient-centered care, it aims to be the leading name in the sleep health industry.
Dec. 2024 - ZQuiet, the trusted leader in snoring solutions since 2008, is proud to introduce the new ZQuiet Advance Anti-Snoring Mouthpiece. This latest innovation joins their award-winning family of products. Based on over 20 years of design innovation, the new ZQuiet Advance sets a benchmark for comfort, custom-fit options, and effectiveness for snoring relief.
The major strength of Fisher & Paykel Healthcare Limited in the anti-snoring devices market revolves around its technological leadership and deep expertise in respiratory care. The company is globally recognized for its innovation in Continuous Positive Airway Pressure (CPAP) and nasal mask systems - technologies that form the foundation of effective snoring and sleep apnea management. Its devices are known for superior comfort, user-friendly design, and clinical effectiveness, making them a preferred choice among patients and sleep specialists. Fisher & Paykel's strong research and development focus enables the company to integrate advanced humidification and breathing technologies that enhance therapy adherence and patient satisfaction. In addition, its global presence, strong brand credibility, and strong distribution network ensure wide accessibility and trust. With continuous innovation aimed at improving sleep quality and reduction of sleep-related breathing disorders, Fisher & Paykel Healthcare remains a market leader in the delivery of effective, comfortable, and reliable anti-snoring solutions worldwide.
Tomed GmbH's key strength in the anti-snoring devices market relates to its specialization, product innovation, and strong focus on user comfort and safety. The company is well-recognized for its line of MADs under the brand name SomnoGuard, clinically proven to reduce snoring and mild obstructive sleep apnea by repositioning the lower jaw to keep the airways open during sleep. All of Tomed's devices boast high-quality medical-grade materials, precise engineering, and ease of adjustability - features that ensure user comfort and compliance. Being a company oriented toward collaboration with sleep specialists and dentists, Tomed certainly meets both clinical and patient demands. Its compact organizational structure offers agility in innovation and a rapid adaptation to emerging trends in sleep medicine. With strong European quality standards and a reputation for reliability, Tomed GmbH has established itself as a trusted and specialized provider in the global anti-snoring device market.
August 2025 - ProSomnus Sleep Technologies, the leader in non-CPAP therapies for Obstructive Sleep Apnea, announced the FDA approval of its HWO2 buccal mucosal wellness oximeter. This device provides monitoring through a smartphone for blood oxygen saturation and pulse rate, among other factors related to overall usage. In a controlled study at the University of Calgary, the HWO2 was found to have an RMSE of 2.94% for oxygen levels and 2.08 bpm for pulse rate accuracy. Its findings indicated that intraoral oximetry might offer significant advantages because of the highly vascular characteristics of the buccal mucosal region and stability against environmental factors.
Anti-snoring devices are those designed to minimize or eliminate snoring, a common problem affecting millions in the world's population. These work by trying to eliminate the basic causes of snoring, which include nasal obstruction, throat muscle relaxation, and even tongue positioning. Examples of common types include mouthguards, nasal strips, and positional aids that encourage side sleeping.
Because people are becoming more conscious of the health dangers associated with snoring, these devices have become very popular over recent years. For example, obstructive sleep apnea has been linked to serious conditions like high blood pressure, heart disease, and sleep deprivation. More people are turning toward anti-snoring solutions as a means to improve their rest amidst growing awareness of quality sleep.
Further, the introduction of e-commerce gave the consumer easier access to different anti-snoring solutions globally. Online reviews and recommendations motivated this interest, leading to a broader level of acceptance and demand for such innovative solutions. Therefore, anti-snore devices represent a market with continuous growth, proposing different options that consider every preference and need.
Top 5 Companies in Anti-Snoring Devices Market
Koninklijke Philips N.V.
Establishment: 1891Headquarters: Netherlands
Koninklijke Philips NV (Philips) is a diversified technology company engaged in the development of medical systems and the manufacturing of consumer electronics products. The company's products are focused on precision diagnosis, image-guided therapy, monitoring, enterprise informatics, sleep and respiratory care, and personal health. Its major products and services include X-ray and fluoroscopy systems, MRI systems, CT systems, integrated interventional X-ray systems, image guided therapy system, ICE catheter, hospital patient monitoring systems, ambulatory monitoring and diagnostics systems, battery-operated toothbrushes, brush heads, breast pumps, baby bottles, sterilizers, groomers, trimmers, and hair clippers, among others. The company's products are distributed to healthcare providers, patients, and consumers in Europe, North America, and Asia.
ResMed, Inc.
Establishment: 1989Headquarters: United States of America
ResMed Inc (ResMed) is a medical device company. It develops, manufactures, and distributes medical equipment for the diagnosis, treatment, and management of respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea, and chronic obstructive pulmonary disease (COPD). Its major products include airflow generators comprising continuous positive airway pressure (CPAP) devices, auto-bilevel devices, variable positive airway pressure (VPAP) devices, and automatic positive airway pressure (APAP) devices. The company distributes its products in various countries through both a combination of distributors and direct sales teams. ResMed also offers software as a service to out-of-hospital health providers. The company sells its products to sleep clinics, home healthcare dealers, and third-party payers.
SomnoMed Limited
Establishment: 1987Headquarters: Australia
SomnoMed Limited is a global leader in the development and manufacturing of innovative oral appliances for the treatment of sleep-related disorders, focusing on Obstructive Sleep Apnea (OSA). This Australian company was founded in 2004 in Sydney and is specialized in the design of effective, patient-friendly solutions that lead to improved quality of sleep and health. The flagship product at SomnoMed is the SomnoDent, which is a custom-made oral device designed to keep the airway open during sleep. It is more comfortable compared to CPAP machines. The company has established an international presence, distributing its products in many countries and expanding further. Committed to research and development, SomnoMed invests significantly in clinical studies to enhance its offerings, aiming to provide healthcare professionals and patients with reliable, effective options for better health regarding sleep.
GSK Plc
Establishment: 2000Headquarters: United Kingdom
GSK plc is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines. GSK's major products encompass specialty medicines, vaccines, and general medicines targeting therapeutic areas such as HIV, respiratory, cancer, immuno-inflammation, anti-viral, central nervous system (CNS), metabolic, cardiovascular, and urogenital, anti-bacterial, dermatology, and rare diseases. The company also offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health, and gastrointestinal diseases. GSK's vaccine portfolio covers various diseases, including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles, and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians, and other groups globally.
Apnea Sciences Corporation
Establishment: 2009Headquarters: United States
Apnea Sciences Corporation is a groundbreaking organization committed to researching and developing novel approaches for diagnosing and treating sleep apnea, among other sleep disorders. Driven by a passion for helping improve the quality of life for those afflicted, it merges advanced medical technology with in-depth research. Its flagship product is a non-invasive device that reduces discomfort and increases patient compliance while offering effective therapy. Emphasizing clinical efficacy and safety, this organization ensures its solutions are scientifically researched and proven. Besides the product offering, Apnea Sciences Corporation actively participates in education and awareness on sleep disorders. With emphasis on patient-centered care, it aims to be the leading name in the sleep health industry.
Product Launches in the Anti-Snoring Devices Market
ZQuiet (Sleeping Well, LLC)Dec. 2024 - ZQuiet, the trusted leader in snoring solutions since 2008, is proud to introduce the new ZQuiet Advance Anti-Snoring Mouthpiece. This latest innovation joins their award-winning family of products. Based on over 20 years of design innovation, the new ZQuiet Advance sets a benchmark for comfort, custom-fit options, and effectiveness for snoring relief.
Airway Management, Inc.
In Oct 2025, Airway Management introduced the Nylon flexTAP, which it claims to be the world’s first digitally printed single-point midline oral appliance for obstructive sleep apnea. The device is FDA-cleared for the treatment of mild to moderate OSA and is said to redefine patient care by combining advanced patented Vertex Technology with enhanced comfort and effectiveness.SWOT Analysis of Company
Fisher & Paykel Healthcare Limited.
Strengths: technological leadership and deep expertise in respiratory careThe major strength of Fisher & Paykel Healthcare Limited in the anti-snoring devices market revolves around its technological leadership and deep expertise in respiratory care. The company is globally recognized for its innovation in Continuous Positive Airway Pressure (CPAP) and nasal mask systems - technologies that form the foundation of effective snoring and sleep apnea management. Its devices are known for superior comfort, user-friendly design, and clinical effectiveness, making them a preferred choice among patients and sleep specialists. Fisher & Paykel's strong research and development focus enables the company to integrate advanced humidification and breathing technologies that enhance therapy adherence and patient satisfaction. In addition, its global presence, strong brand credibility, and strong distribution network ensure wide accessibility and trust. With continuous innovation aimed at improving sleep quality and reduction of sleep-related breathing disorders, Fisher & Paykel Healthcare remains a market leader in the delivery of effective, comfortable, and reliable anti-snoring solutions worldwide.
Tomed GmbH
Strengths: Specialization, product innovation, and strong focus on user comfort and safetyTomed GmbH's key strength in the anti-snoring devices market relates to its specialization, product innovation, and strong focus on user comfort and safety. The company is well-recognized for its line of MADs under the brand name SomnoGuard, clinically proven to reduce snoring and mild obstructive sleep apnea by repositioning the lower jaw to keep the airways open during sleep. All of Tomed's devices boast high-quality medical-grade materials, precise engineering, and ease of adjustability - features that ensure user comfort and compliance. Being a company oriented toward collaboration with sleep specialists and dentists, Tomed certainly meets both clinical and patient demands. Its compact organizational structure offers agility in innovation and a rapid adaptation to emerging trends in sleep medicine. With strong European quality standards and a reputation for reliability, Tomed GmbH has established itself as a trusted and specialized provider in the global anti-snoring device market.
Recent Development in Anti-Snoring Devices Market
ProSomnus Sleep Technologies (US)August 2025 - ProSomnus Sleep Technologies, the leader in non-CPAP therapies for Obstructive Sleep Apnea, announced the FDA approval of its HWO2 buccal mucosal wellness oximeter. This device provides monitoring through a smartphone for blood oxygen saturation and pulse rate, among other factors related to overall usage. In a controlled study at the University of Calgary, the HWO2 was found to have an RMSE of 2.94% for oxygen levels and 2.08 bpm for pulse rate accuracy. Its findings indicated that intraoral oximetry might offer significant advantages because of the highly vascular characteristics of the buccal mucosal region and stability against environmental factors.
Zyppah
October 2024 Cellev8 and Zyppah Announce Groundbreaking Collaborative Sales Agreement to Help 90 Million Snoring Americans Sleep Better Today, Cellev8, the industry leader in Superoxide Dismutase (SOD) gummies, and Zyppah, the leading patented anti-snoring device innovator, announced a game-changing collaborative sales agreement. By joining forces, the companies look to address the estimated 90 million Americans affected by snoring with one comprehensive solution for better sleep and enhanced recovery.Sustainability Goal
Rhinomed Limited
Rhinomed is committed to fostering sustainability through responsible innovation, ethical manufacturing, and environmental stewardship. As a developer of nasal and respiratory technologies, Rhinomed addresses sustainability in the development of new products and operational practices. The company aims to reduce its overall environmental impact by utilizing recyclable materials and reducing the amount of plastics used in product packaging and components. Sustainable design guides each product throughout its lifecycle-from sourcing and production through to distribution-to ensure minimal consumption of resources and waste. In addition, Rhinomed seeks to reduce its carbon footprint by optimizing supply chain efficiency, while seeking to source materials from suppliers that conduct business in a responsible manner. Furthermore, social sustainability is an important element of Rhinomed's operations, focusing on ethical labor and community involvement, as well as the advancement of respiratory health around the world. By combining innovation in breathing technology with concern for the environment, Rhinomed aims to offer high-performance products, contributing to human well-being and supporting a cleaner and more sustainable future.The Pure Sleep Company
The Pure Sleep Company is all about sustainability, embedding ecological awareness into product design, manufacturing, and the corporate approach. Focusing on enhancing sleep health through oral appliance therapy, the company continues to strive for a balance between innovation and ecological responsibility. It has set various sustainability goals, such as minimizing waste from manufacturing, using eco-friendly and recyclable materials, and minimizing energy use in all phases of its production. The Pure Sleep Company focuses on sustainable packaging solutions and effective distribution networks to cut down its carbon footprint. Moreover, product longevity within the company is promoted by designing long-lasting and reusable sleep devices that decrease medical waste compared to disposable alternatives. Besides environmental initiatives, social sustainability within The Pure Sleep Company is pursued by practicing ethical business, operating transparently, and embracing patient safety and education. As it aligns its business strategy with the principles of sustainable development, it offers value to both improved sleep health and a more responsible, eco-conscious healthcare industry.Market Segmentation
Anti-Snoring Devices Market
- Historical Trends
- Forecast Analysis
Market Share Analysis - Anti-Snoring Devices Market
Koninklijke Philips N.V
Overview
- Company History and Mission
- Business Model and Operations
Workforce
Key Persons
- Executive Leadership
- Operational Management
- Division Leaders
- Board Composition
Recent Development & Strategies
- Mergers & Acquisitions
- Partnerships
- Investments
Sustainability Analysis
- Renewable Energy Adoption
- Energy-Efficient Infrastructure
- Use of Sustainable Packaging Materials
- Water Usage and Conservation Strategies
- Waste Management and Circular Economy Initiatives
Product Analysis
- Product Profile
- Quality Standards
- Product Pipeline
- Product Benchmarking
Strategic Assessment: SWOT Analysis
- Strengths
- Weaknesses
- Opportunities
- Threats
Revenue Analysis
The above information will be available for all the following companies:
- Koninklijke Philips N.V
- ResMed, Inc.
- SomnoMed Limited
- GSK Plc
- Apnea Sciences Corporation
- ZQuiet (Sleeping Well, LLC)
- Airway Management, Inc.
- Fisher & Paykel Healthcare Limited.
- Tomed GmbH
- ProSomnus Sleep Technologies (US)
- Theravent, Inc.
- Rhinomed Limited
- The Pure Sleep Company
- MPowRx Health & Wellness Products
- ZZyppah, Inc.
Table of Contents
1. Anti-snoring Device Market
3. Koninklijke Philips N.V.
The above information will be available for all the following companies:
Companies Mentioned
- Koninklijke Philips N.V
- ResMed, Inc.
- SomnoMed Limited
- GSK Plc
- Apnea Sciences Corporation
- ZQuiet (Sleeping Well, LLC)
- Airway Management, Inc.
- Fisher & Paykel Healthcare Limited.
- Tomed GmbH
- ProSomnus Sleep Technologies (US)
- Theravent, Inc.
- Rhinomed Limited
- The Pure Sleep Company
- MPowRx Health & Wellness Products
- ZZyppah, Inc.
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | December 2025 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 1.81 Billion |
| Forecasted Market Value ( USD | $ 3.36 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
